Surgery
Volume 148, Issue 3 , Pages 490-498 , September 2010

The role of interleukin-1β and platelet-derived growth factor-AB in antifibrosis mediated by native human interferon α

  • Goran Šantak, MD

      Affiliations

    • Department of Surgery, General County Hospital, Požega, Croatia
    • Corresponding Author InformationReprint requests: Goran Šantak, MD, Department of Surgery, General County Hospital, Osječka 107, HR 34 000 Požega, Croatia.
    • ,
  • Maja Šantak, PhD

      Affiliations

    • Research and Development Department, Institute of Immunology, Zagreb, Croatia
    • ,
  • Dubravko Forčić, PhD

      Affiliations

    • Research and Development Department, Institute of Immunology, Zagreb, Croatia

,Accepted 11 January 2010.

References 

  1. Lissoos TW, Davis BH. Pathogenesis of hepatic fibrosis and the role of cytokines. J Clin Gastroenterol. 1992;15:63–67
  2. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989–2003
  3. Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009;2:103–121
  4. Kosaka H, Yoshimoto T, Yoshimoto T, Fujimoto J, Nakanishi K. Interferon-γ is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med. 2008;14:437–441
  5. Nedelec B, Shankowsky H, Scott PG, Ghahary A, Tredget EE. Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-α2b. Surgery. 2001;130:798–808
  6. Tarantino G, Conca P, Ariello M, Mastrolia M, Di Minno MN. The use of interferon-alpha in a small cohort of patients with a type of idiopathic pulmonary fibrosis, probably post-cryoglobulinaemia, hepatitis C virus related. Eur J Gastroenterol Hepatol. 2005;17:1439–1440
  7. Wang J, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Improvement in postburn hypertrophic scar after treatment with IFN-alpha2b is associated with decreased fibrocytes. J Interferon Cytokine Res. 2007;27:921–930
  8. Antonelli G. Biological basis for a proper clinical application of alpha interferons. New Microbiol. 2008;31:305–318
  9. Ghahary A, Tredget EE, Shen Q, Kilani RT, Scott PG, Takeuchi M. Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig. Mol Cell Biochem. 2000;208:129–137
  10. Tredget EE, Shankowsky HA, Pannu R, Nedelec B, Iwashina T, Ghahary A, et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg. 1998;102:1317–1328
  11. Nyman TA, Tolo H, Parkkinen J, Kalkkinen N. Identification of nine interferon-α subtypes produced by Sendai virus induced human peripheral blood leucocytes. Biochem J. 1998;329:295–302
  12. Zidovec S, Mazuran R. Immunogenic PDGF-AB dimers in crude leukocyte interferon batches. Cytokine. 1998;10:70–72
  13. Zidovec S, Mazuran R. Sendai virus induces various cytokines in human peripheral blood leukocytes: different susceptibility of cytokine molecules to low pH. Cytokine. 1999;11:140–143
  14. Adolf GR. Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN. Virology. 1990;175:410–417
  15. Santak G, Santak M, Forcić D. Native human IFN-alpha is a more potent suppressor of HDF response to profibrotic stimuli than recombinant human IFN-alpha. J Interferon Cytokine Res. 2007;27:481–490
  16. Adolf GR, Kalsner I, Ahorn H, Maurer-Fogy I, Cantell K. Natural human interferon-alpha 2 is O-glycosylated. Biochem J. 1991;276:511–518
  17. Dipaola M, Smith T, Ferencz-Biro K, Liao MJ, Testa D. Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b. J Interferon Res. 1994;14:325–332
  18. Hua J, Liao MJ, Rashidbaigi A. Cytokines induced by Sendai virus in human peripheral blood leukocytes. J Leukoc Biol. 1996;60:125–128
  19. Thomopoulos S, Zaegel M, Das R, Harwood FL, Silva MJ, Amiel D, et al. PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling. J Orthop Res. 2007;25:1358–1368
  20. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283–1316
  21. Vesey DA, Cheung C, Cuttle L, Endre Z, Gobe G, Johnson DW. Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med. 2002;140:342–350
  22. Lertchirakarn V, Birner R, Messer HH. Effects of interleukin-1 beta on human pulpal fibroblast proliferation and collagen synthesis. J Endod. 1998;24:409–413
  23. Clement-Lacroix P, Friteau L, Damais C. Activation of human dermal fibroblasts by fibroblast growth factors (FGFs) and/or interleukin-1 beta (IL-1 beta). Lymphokine Cytokine Res. 1991;10:111–114
  24. Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004;15:255–273
  25. Knorr M, Völker M, Denk PO, Wunderlich K, Thiel HJ. Proliferative response of cultured human tenon's capsule fibroblasts to platelet-derived growth factor isoforms. Graefes Arch Clin Exp Ophthalmol. 1997;235:667–671
  26. Clark JG, Madtes DK, Raghu G. Effects of platelet-derived growth factor isoforms on human lung fibroblast proliferation and procollagen gene expression. Exp Lung Res. 1993;19:327–344
  27. Lepistö J, Peltonen J, Vähä-Kreula M, Niinikoski J, Laato M. Platelet-derived growth factor isoforms PDGF-AA, -AB and -BB exert specific effects on collagen gene expression and mitotic activity of cultured human wound fibroblasts. Biochem Biophys Res Commun. 1995;209:393–399
  28. Lepistö J, Peltonen J, Vähä-Kreula M, Söderström K, Niinikoski J, Laato M. Selective modulation of collagen gene expression by different isoforms of platelet-derived growth factor in experimental wound healing. Cell Tissue Res. 1996;286:449–455
  29. Sasaki M, Kashima M, Ito T, Watanabe A, Izumiyama N, Sano M, et al. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha. Mediators Inflamm. 2000;9:155–160
  30. Zhang ZJ, Muhr C, Wang JL. Interferon-alpha inhibits the DNA synthesis induced by PDGF and EGF in cultured meningioma cells. Anticancer Res. 1996;16:717–723
  31. Tamm I, Kikuchi T, Kreutter D, Pledger WJ, Pfeffer LM. Selective interferon-alpha/beta effects on platelet-derived growth factor-stimulated processes in quiescent BALB/c-3T3 fibroblasts. J Interferon Res. 1994;14:265–273
  32. Inglot AD, Oleszak E, Kisielow B. Antagonism in action between mouse or human interferon and platelet growth factor. Arch Virol. 1980;63:291–296
  33. Diaz A, Munoz E, Johnston R, Korn JH, Jimenez SA. Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. J Biol Chem. 1993;268:10364–10371
  34. Rapala K, Heino J, Peltonen J, Laato M. The effects of interleukin-1 and prostaglandin E2 on accumulation of collagen and steady-state levels of pro alpha 1(I) collagen messenger RNA in experimental granulation tissue in rats. Arch Dermatol Res. 1997;289:219–223
  35. Siwik DA, Chang DL, Colucci WS. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res. 2000;86:1259–1265
  36. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH. Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol. 1988;106:311–318
  37. Tiggelman AM, Boers W, Linthorst C, Sala M, Chamuleau RA. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. J Hepatol. 1995;23:307–317
  38. Mauviel A, Heino J, Kähäri VM, Hartmann DJ, Loyau G, Pujol JP, et al. Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol. 1991;96:243–249
  39. Tan EM, Qin H, Kennedy SH, Rouda S, Fox JW, Moore JH. Platelet-derived growth factors-AA and -BB regulate collagen and collagenase gene expression differentially in human fibroblasts. Biochem J. 1995;310:585–588
  40. Santavenere E, Di Pietro R, Centurione MA, Di Domenicantonio L, Trubiani O, Rana RA. Synergistic regulatory effects of TNF alpha, IL-1 alpha and IFN alpha on the growth and differentiation of Daudi lymphoma cells. Cell Biol Int. 1996;20:335–338
  41. Struyf S, Van Collie E, Paemen L, Put W, Lenaerts JP, Proost P, et al. Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells. J Leukoc Biol. 1998;63:364–372
  42. Lindroos PM, Coin PG, Badgett A, Morgan DL, Bonner JC. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism. Am J Respir Cell Mol Biol. 1997;16:283–292
  43. Wang XZ, Zhang SJ, Chen YX, Chen ZX, Huang YH, Zhang LJ. Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro. World J Gastroenterol. 2004;10:2706–2710
  44. Chen CN, Li YS, Yeh YT, Lee PL, Usami S, Chien S, et al. Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells. Proc Natl Acad Sci U S A. 2006;103:2665–2670

PII: S0039-6060(10)00015-2

doi: 10.1016/j.surg.2010.01.005

Surgery
Volume 148, Issue 3 , Pages 490-498 , September 2010

Article Tools

* Image Usage & Resolution